Hledání článků
Filtry
Ruggenenti P, Perticucci E, Cravedi P, et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008;19:1213–1224.
van Gurp E, Weimar W, Gaston R, et al. Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics. Am J Transplant 2008;8:1711–1718.
Ishani A, Blackell T, Jamal SA, et al. for the MORE Investigators. The effect of raloxifen treatment in postmenopausal women with CKD. J Am Soc Nephrol 2008;19:1430–1438.
Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex® predict late graft loss. Am J Transplant 2008;8:2335–2342.
Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008, Epub ahead of print on Sept. 17.
Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2008, Epub aheat of print on Oct 8.
Tong A, Chapman S, Sainsbury P, Craig JC. An analysis of media coverage on the prevention and early detection of CKD in Australia. Am J Kidney Dis 2008; 52:159–170.
Koyner JL, Bennett MR, Worchester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008,74:1059–1069.
Axelsson J. The emerging biology of adipose tissue in chronic kidney disease: from fat to facts. Nephrol Dial Transpl 2008;23:3041–3046.
Harada K, Akai Y, Yamaguchi Y, Kimura K, Nishitani Y, Nakatani K, Iwano M, Saito Y. Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy. Nephrol Dial Transplant 2008;23:3152–3159.
Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gama release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008;3:1357–1363.